Medical Product Outsourcing Magazine
May 2022
-
Cybersecurity Challenges Leave Medical Device Makers Insecure
Mounting attacks against the healthcare sector demonstrate the need for stronger security measures.05.02.22
-
OEMs Are Demanding Designs that Challenge Suppliers
Innovative technologies enable outsourcing providers to offer design solutions to OEMs with complex requirements.05.02.22
-
Diabetes Technology Manufacturers Seemingly on a Sugar Rush
Examining recent diabetes technology innovations and market trends as well as manufacturing partners to the industry.05.02.22
-
Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion
Lessons learned during COVID-19 will have a lasting impact on the outsourcing service provider/OEM relationship for years to come.05.02.22
-
Software DevelopmentPreparing for a More Digital Future in Medtech Clinical TrialsThe length of the medtech product development lifecycle drives the industry to find ways to accelerate clinical trials.05.02.22
-
The Supply ChainThe Impact of Digital Transformation on the Healthcare Supply ChainEven before the COVID-19 pandemic, the healthcare industry was undergoing significant changes.05.02.22
-
Design ViewpointHow to Tune Up Your Outsourcing StrategyAn engineering firm must know the project’s scope to estimate properly.05.02.22
-
Dollars & SenseAdapting to COVID’s Lasting Impact on HealthcareThe pandemic has forever changed the healthcare market’s day-to-day operations and long-term strategy.05.02.22
-
Regulatory PerspectivesOutsourcing vs. In-House Chemical Characterization TestingOutsourcing pre-clinical safety testing or keeping it in-house is a nuanced and multi-factored decision.05.02.22
-
Process ImprovementManaging Critical Healthcare Supply Chains in Turbulent TimesOur interconnected global economy has been disrupted, and remains vulnerable.05.02.22
-
Medtech MusingsInjecting Neurostimulators into Blood Vessels (We Swear, It’s Not Sci-Fi)Houston’s Rice University believes PNS technology could be reduced to about the size of a grain of rice.05.02.22
-
Editorial‘The Dropout’—Medtech’s Theranos Scandal on TelevisionThe eight-episode series tells the life of Elizabeth Holmes and the rise and fall of her company Theranos.05.02.22
-
DatawatchUnderstanding the Costs of Care in the ORSomehow, the cost of operating in the OR never seems to decline.05.02.22
-
Best PracticesSick of Being Sick: Pandemic Fatigue Flares at AAOSFor the second time in less than a year, I surveyed the exhibit hall of the American Academy of Orthopedic Surgeons’ biggest event.05.02.22
-
ColumnsTo Drive Value, Human Capital Leaders Turn to Outsourced SolutionsWith the growth of talent scarcity in the labor market, interest in outsourced HR services is rising.05.02.22
-
ColumnsM&A in Turbulent Times—Bullish or Bearish?M&A deal volume in the medical device contract manufacturing market rebounded dramatically last year.05.02.22
-
ColumnsIs a Quality Management System Really Necessary?The technical answer lies in the details of exactly what you’re doing, for whom you are doing it, and for what geography.05.02.22
